Understanding Willingness to Participate in Cancer Clinical Trials Among Patients and Caregivers Attending a Minority-Serving Academic Cancer Center
- PMID: 32666504
- PMCID: PMC10685662
- DOI: 10.1007/s13187-020-01802-5
Understanding Willingness to Participate in Cancer Clinical Trials Among Patients and Caregivers Attending a Minority-Serving Academic Cancer Center
Abstract
Advances in cancer treatment are impeded by low accrual rates of patients to cancer clinical trials (CCTs). The national rates of recruitment of underserved groups, including racial/ethnic minorities, are limiting the generalizability of research findings and are likely to enhance inequities in cancer outcomes. The goal of this study was to examine willingness to participate (WTP) in CCTs and factors associated with this willingness among patients and caregivers attending a minority-serving university cancer center in the Southwest. A cross-sectional survey design was utilized (n = 236, 135 patients and 101 caregivers). Fear was the strongest predictor of WTP in CCTs. The only ethnic differences observed related to Spanish-speaking patients exhibiting increased WTP in CCTs, and Spanish-speaking caregivers' decreased WTP, compared to others. These results underscore the importance of future interventions to reduce CCT-related fear among patients and caregivers, with particular need for family-focused tailored interventions designed to meet the needs of Spanish-speaking patients and caregivers.
Keywords: Cancer communication; Caregivers; Clinical trials; Health disparities; Hispanics/Latinx; Rural patients.
© 2020. American Association for Cancer Education.
Similar articles
-
Disparities in awareness of and willingness to participate in cancer clinical trials between African American and White cancer survivors.BMC Cancer. 2022 Sep 15;22(1):983. doi: 10.1186/s12885-022-10082-9. BMC Cancer. 2022. PMID: 36109780 Free PMC article.
-
Interventions to increase racial and ethnic minority accrual into cancer clinical trials: A systematic review.Cancer. 2022 Nov 1;128(21):3860-3869. doi: 10.1002/cncr.34454. Epub 2022 Sep 15. Cancer. 2022. PMID: 36107740 Free PMC article.
-
Evaluation of factors affecting awareness of and willingness to participate in cancer clinical trials.J Clin Oncol. 2005 Dec 20;23(36):9282-9. doi: 10.1200/JCO.2005.02.6245. J Clin Oncol. 2005. PMID: 16361626
-
Participation of Patients From Racial and Ethnic Minority Groups in Phase 1 Early Cancer Drug Development Trials in the US, 2000-2018.JAMA Netw Open. 2022 Nov 1;5(11):e2239884. doi: 10.1001/jamanetworkopen.2022.39884. JAMA Netw Open. 2022. PMID: 36326764 Free PMC article. Clinical Trial.
-
Are racial and ethnic minorities less willing to participate in health research?PLoS Med. 2006 Feb;3(2):e19. doi: 10.1371/journal.pmed.0030019. Epub 2005 Dec 6. PLoS Med. 2006. PMID: 16318411 Free PMC article. Review.
Cited by
-
Enhancing Public Health Communication Regarding Vaccine Trials: Design and Development of the Pan-European VACCELERATE Toolkit.JMIR Public Health Surveill. 2023 Apr 3;9:e44491. doi: 10.2196/44491. JMIR Public Health Surveill. 2023. PMID: 36878478 Free PMC article.
-
The status quo and influencing factors of clinical research nurses' participation in preoperative blood sampling in patients with pulmonary nodules.J Res Nurs. 2024 Aug;29(4-5):334-345. doi: 10.1177/17449871241246971. Epub 2024 Aug 12. J Res Nurs. 2024. PMID: 39291219 Free PMC article.
-
Reimagining diversity in multiple myeloma clinical trials.Hematol Oncol. 2022 Oct;40(4):689-694. doi: 10.1002/hon.2997. Epub 2022 Apr 13. Hematol Oncol. 2022. PMID: 35391496 Free PMC article. No abstract available.
References
-
- Ford JG, Howerton MW, Lai GY, Gary TL, Bolen S, Gibbons MC, Tilburt J, Baffi C, Tanpitukpongse TP, Wilson RF, Powe NR, Bass EB (2008) Barriers to recruiting underrepresented populations to cancer clinical trials: a systematic review. Cancer 112(2):228–242 - PubMed
-
- Mills EJ, Seely D, Rachlis B, Griffith L, Wu P, Wilson K, Ellis P, Wright JR (2006) Barriers to participation in clinical trials of cancer: a meta-analysis and systematic review of patient-reported factors. The Lancet Oncology 7(2):141–148 - PubMed
-
- Lara PN et al. (2001) Prospective evaluation of cancer clinical trial accrual patterns: identifying potential barriers to enrollment. J Clin Oncol 19(6):1728–1733 - PubMed
-
- Doroshow JH (2013) Timely completion of scientifically rigorous Cancer clinical trials: an unfulfilled priority. J Clin Oncol 31(27): 3312–3314 - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical